|Articles|June 13, 2003
Latest Medical and Laser Therapy
Chicago-Reducing the IOP level is the first goal when treating patientswith open-angle glaucoma. The latest research indicates that keeping IOPin check benefits patients by protecting the optic nerve from damage andpreserving the visual field. However, individualized patient treatment todetermine the IOP range that works best to control IOP is the challenge.Stephen A. Obstbaum, MD, discussed setting that range for individual patientsand the most beneficial therapy with a workable risk/benefit ratio-bothof which should meet the ultimate challenge of preserving vision and qualityof life.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























